NicOx Envisions Co-Commercialization And In-Licensing Strategy Around Naproxcinod
This article was originally published in The Pink Sheet Daily
Executive Summary
French firm plans to build U.S. sales force to market osteoarthritis drug and complementary products it will acquire or license.